Prometheus Biosciences, Inc., (RXDX) Stock Charts

Warning: This security is no longer trading. Roche has completed deal to acquire Ignyta, Inc.

Prometheus Biosciences, Inc., (RXDX): $108.68

0.25 (+0.23%)

POWR Rating

Component Grades

Sign Up to See Ratings...FREE!

We have 9 different ratings for every stock to help you appreciate its future potential. You can unlock it all now.
Just click the link above.

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add RXDX to Watchlist
Sign Up

Industry: Biotech

Ranked

of NR

in industry

See All 'A' Rated Buy Stocks

Prometheus Biosciences, Inc., (RXDX) Performance Graph for POWR Ratings

Prometheus Biosciences, Inc., (RXDX) Interactive Chart

Prometheus Biosciences, Inc., (RXDX) Ratings History Chart

Free access to the full ratings history for RXDX. Sign up now!

Most Popular Stories View All

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Get Free Updates

Page generated in 0.323 seconds.